comprehensive -WSS

comprehensive

author：focus 2025-10-02 23:31:07 - browse：9789

ADAM FEUERSTEIN/STAT

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up here.

CHICAGO — It’s only Day 2, but the ASCO meeting is already in full force. That means hordes of oncologists filling the halls, reams of data streaming through the meeting, and incredibly long lines for even the worst food. And STAT reporters Angus Chen, Adam Feuerstein, and Matthew Herper are in the thick of it – on the heels of STAT’s own in-person event here, which was standing room only and came with its own share of thrills, chills, and not a little bit of audience laughter. More on that in a bit.

Here’s a rundown of some of the big news from the first 24 hours of the meeting which, due to some weird kind of relativistic time dilation, represents about a week for our intrepid reporters.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： FDA's Woodcock to retire early next year

leisure time

WSS

Judge agrees to delay next hearing in Trump classified documents case

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Teachers share how revamped forgiveness program helped with their student loans

Pandemic and All Hazards Preparedness Act needs lean update

DeSantis defends odds vs. Trump, despite early poll gap: 'We've worked really hard'

focus

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

hotspot

Medicare details structure of new drug price negotiation program

Biden targets hefty hospital 'facility fees' that often surprise patients

Malaria cases in Florida and Texas: Here’s what you need to know

Weight loss drug costs may need more research, senator suggests

Moonlake's readout produced a cash windfall. Risks remain

A daunting task: navigating dual Medicare, Medicaid eligibility

Bright Health sells Medicare Advantage business to Molina

ACA's risk program benefits Blue Cross Blue Shield insurers

Malaria cases in Florida and Texas: Here’s what you need to know

ACA's risk program benefits Blue Cross Blue Shield insurers

leisure time

ACA's risk program benefits Blue Cross Blue Shield insurers

U.K. considers world's first use of meningitis vaccine to address gonorrhea

In key trial, Verve's treatment lowers cholesterol levels in patients

The aspartame in Diet Coke probably isn’t giving you cancer

Judge agrees to delay next hearing in Trump classified documents case

ACA's risk program benefits Blue Cross Blue Shield insurers

focus

knowledge

leisure time

leisure time